SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-14-096618
Filing Date
2014-03-13
Accepted
2014-03-13 06:10:59
Documents
1
Group Members
JON M. PLEXICOSTONEPINE CAPITAL MANAGEMENT, LLCTIMOTHY P. LYNCH

Document Format Files

Seq Description Document Type Size
1 SC 13G d692810dsc13g.htm SC 13G 80517
  Complete submission text file 0001193125-14-096618.txt   82455
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-35587 | Film No.: 14689566
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 475 GATE FIVE RD., SUITE 320 SAUSALITO CA 94965
Business Address 475 GATE FIVE RD., SUITE 320 SAUSALITO CA 94965 415.331.7100
STONEPINE CAPITAL L P (Filed by) CIK: 0001370042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G